Topical drug addiction: adverse effects of fluorinated corticosteroid creams and ointments.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001284:Atrophy / Q000139:chemically induced; D001446:Balanitis / Q000139:chemically induced; D001623:Betamethasone / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology; D005148:Facial Dermatoses / Q000139:chemically induced; D005260:Female; D005446:Fluocinolone Acetonide / Q000009:adverse effects / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011693:Purpura / Q000139:chemically induced; D012393:Rosacea / Q000188:drug therapy; D012883:Skin Ulcer / Q000139:chemically induced; D019966:Substance-Related Disorders; D013684:Telangiectasis / Q000139:chemically induced; D014005:Tinea / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; D005446:Fluocinolone Acetonide; D001623:Betamethasone